nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergoloid mesylate—Bromocriptine—type 2 diabetes mellitus	0.454	1	CrCtD
Ergoloid mesylate—Dihydroergotamine—Bromocriptine—type 2 diabetes mellitus	0.175	0.663	CrCrCtD
Ergoloid mesylate—Ergotamine—Bromocriptine—type 2 diabetes mellitus	0.0887	0.337	CrCrCtD
Ergoloid mesylate—CYP3A4—type 2 diabetes mellitus	0.0799	1	CbGaD
Ergoloid mesylate—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.0546	0.296	CbGbCtD
Ergoloid mesylate—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.0314	0.17	CbGbCtD
Ergoloid mesylate—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0268	0.145	CbGbCtD
Ergoloid mesylate—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0882	CbGbCtD
Ergoloid mesylate—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00845	0.0457	CbGbCtD
Ergoloid mesylate—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00753	0.0408	CbGbCtD
Ergoloid mesylate—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00688	0.0373	CbGbCtD
Ergoloid mesylate—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00602	0.0326	CbGbCtD
Ergoloid mesylate—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00544	0.0295	CbGbCtD
Ergoloid mesylate—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00412	0.0223	CbGbCtD
Ergoloid mesylate—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00395	0.0214	CbGbCtD
Ergoloid mesylate—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00395	0.0214	CbGbCtD
Ergoloid mesylate—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00374	0.0203	CbGbCtD
Ergoloid mesylate—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00279	0.0151	CbGbCtD
Ergoloid mesylate—CYP3A4—Losartan—type 2 diabetes mellitus	0.00255	0.0138	CbGbCtD
Ergoloid mesylate—Dihydroergotamine—ADRA2A—type 2 diabetes mellitus	0.000316	0.219	CrCbGaD
Ergoloid mesylate—Ergotamine—ADRA2A—type 2 diabetes mellitus	0.000163	0.113	CrCbGaD
Ergoloid mesylate—Bromocriptine—ADRA2A—type 2 diabetes mellitus	0.000157	0.109	CrCbGaD
Ergoloid mesylate—Ergotamine—HTR2C—type 2 diabetes mellitus	0.00015	0.104	CrCbGaD
Ergoloid mesylate—Dihydroergotamine—CYP3A4—type 2 diabetes mellitus	0.000145	0.101	CrCbGaD
Ergoloid mesylate—Bromocriptine—HTR2C—type 2 diabetes mellitus	0.000145	0.1	CrCbGaD
Ergoloid mesylate—Ergotamine—CYP1A2—type 2 diabetes mellitus	0.000113	0.0783	CrCbGaD
Ergoloid mesylate—Bromocriptine—CYP1A2—type 2 diabetes mellitus	0.000109	0.0755	CrCbGaD
Ergoloid mesylate—Ergotamine—CYP3A4—type 2 diabetes mellitus	7.49e-05	0.0518	CrCbGaD
Ergoloid mesylate—Bromocriptine—CYP3A4—type 2 diabetes mellitus	7.22e-05	0.05	CrCbGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	6.1e-06	0.000367	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.07e-06	0.000365	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.05e-06	0.000364	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.05e-06	0.000364	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.02e-06	0.000362	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	5.95e-06	0.000358	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.94e-06	0.000357	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	5.93e-06	0.000357	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	5.88e-06	0.000354	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	5.8e-06	0.000349	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—C3—type 2 diabetes mellitus	5.8e-06	0.000349	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.76e-06	0.000347	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.61e-06	0.000337	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.59e-06	0.000337	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.59e-06	0.000337	CbGpPWpGaD
Ergoloid mesylate—DRD2—Circadian rythm related genes—IL6—type 2 diabetes mellitus	5.55e-06	0.000334	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	5.52e-06	0.000332	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.51e-06	0.000332	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	5.47e-06	0.000329	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.44e-06	0.000327	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	5.42e-06	0.000326	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	5.42e-06	0.000326	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.42e-06	0.000326	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.42e-06	0.000326	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	5.34e-06	0.000321	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.33e-06	0.00032	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.3e-06	0.000319	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.3e-06	0.000319	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RBP4—type 2 diabetes mellitus	5.28e-06	0.000318	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	5.28e-06	0.000318	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AVP—type 2 diabetes mellitus	5.27e-06	0.000317	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	5.27e-06	0.000317	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	5.24e-06	0.000315	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.24e-06	0.000315	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	5.21e-06	0.000313	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	5.21e-06	0.000313	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	5.2e-06	0.000313	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.09e-06	0.000306	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	5.01e-06	0.000302	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	4.94e-06	0.000297	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	4.93e-06	0.000297	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	4.93e-06	0.000297	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.93e-06	0.000297	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.91e-06	0.000295	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.85e-06	0.000292	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.85e-06	0.000292	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—C3—type 2 diabetes mellitus	4.82e-06	0.00029	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.77e-06	0.000287	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	4.76e-06	0.000286	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.76e-06	0.000286	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	4.71e-06	0.000283	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	4.71e-06	0.000283	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IAPP—type 2 diabetes mellitus	4.68e-06	0.000282	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INSR—type 2 diabetes mellitus	4.65e-06	0.00028	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	4.58e-06	0.000276	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	4.57e-06	0.000275	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	4.56e-06	0.000275	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	4.54e-06	0.000273	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.54e-06	0.000273	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	4.48e-06	0.00027	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.46e-06	0.000268	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.46e-06	0.000268	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—C3—type 2 diabetes mellitus	4.38e-06	0.000263	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	4.35e-06	0.000262	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	4.34e-06	0.000261	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	4.34e-06	0.000261	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.23e-06	0.000255	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.22e-06	0.000254	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.22e-06	0.000254	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.22e-06	0.000254	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	4.2e-06	0.000252	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.2e-06	0.000252	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	4.2e-06	0.000252	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	4.2e-06	0.000252	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	4.2e-06	0.000252	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.18e-06	0.000251	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.16e-06	0.00025	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.12e-06	0.000248	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.12e-06	0.000248	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.11e-06	0.000247	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.11e-06	0.000247	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.09e-06	0.000246	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.09e-06	0.000246	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.09e-06	0.000246	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	4.06e-06	0.000244	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.05e-06	0.000243	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.02e-06	0.000242	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	4e-06	0.000241	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	4e-06	0.000241	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.99e-06	0.00024	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.97e-06	0.000239	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.96e-06	0.000238	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.92e-06	0.000236	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.85e-06	0.000231	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	3.84e-06	0.000231	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	3.84e-06	0.000231	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.81e-06	0.000229	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	3.74e-06	0.000225	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.73e-06	0.000224	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.73e-06	0.000224	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.71e-06	0.000223	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	3.66e-06	0.00022	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3.66e-06	0.00022	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	3.6e-06	0.000217	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	3.59e-06	0.000216	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.57e-06	0.000215	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	3.57e-06	0.000215	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	3.57e-06	0.000215	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	3.57e-06	0.000215	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.51e-06	0.000211	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.43e-06	0.000206	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—C3—type 2 diabetes mellitus	3.43e-06	0.000206	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	3.42e-06	0.000206	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	3.42e-06	0.000206	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.37e-06	0.000203	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.36e-06	0.000202	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.29e-06	0.000198	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.29e-06	0.000198	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.27e-06	0.000197	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.26e-06	0.000196	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.26e-06	0.000196	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3.23e-06	0.000195	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.2e-06	0.000193	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.19e-06	0.000192	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.19e-06	0.000192	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.19e-06	0.000192	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	3.18e-06	0.000191	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	3.18e-06	0.000191	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	3.18e-06	0.000191	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.16e-06	0.00019	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.15e-06	0.00019	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	3.11e-06	0.000187	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.11e-06	0.000187	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.1e-06	0.000186	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.09e-06	0.000186	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.05e-06	0.000184	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	3.01e-06	0.000181	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.01e-06	0.000181	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3e-06	0.00018	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.99e-06	0.00018	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.96e-06	0.000178	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.87e-06	0.000173	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.85e-06	0.000171	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.81e-06	0.000169	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.8e-06	0.000168	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—INS—type 2 diabetes mellitus	2.73e-06	0.000164	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.7e-06	0.000163	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.7e-06	0.000163	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.7e-06	0.000163	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.7e-06	0.000163	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.7e-06	0.000162	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.68e-06	0.000161	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.65e-06	0.000159	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.64e-06	0.000159	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.63e-06	0.000158	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.62e-06	0.000158	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.59e-06	0.000156	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	2.59e-06	0.000156	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.5e-06	0.000151	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.47e-06	0.000148	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.46e-06	0.000148	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.46e-06	0.000148	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.42e-06	0.000145	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.41e-06	0.000145	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.41e-06	0.000145	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.41e-06	0.000145	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.39e-06	0.000144	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.39e-06	0.000144	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.38e-06	0.000143	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.27e-06	0.000137	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.25e-06	0.000135	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.25e-06	0.000135	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.2e-06	0.000133	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.2e-06	0.000133	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.16e-06	0.00013	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.15e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.15e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.15e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.15e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.13e-06	0.000128	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.1e-06	0.000126	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.07e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	2.06e-06	0.000124	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.05e-06	0.000123	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.03e-06	0.000122	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.02e-06	0.000122	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.02e-06	0.000121	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.99e-06	0.00012	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.99e-06	0.00012	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.98e-06	0.000119	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.93e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.93e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.93e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.92e-06	0.000115	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.9e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.89e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.89e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.87e-06	0.000113	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.86e-06	0.000112	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.83e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.8e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.8e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.77e-06	0.000106	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.76e-06	0.000106	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.74e-06	0.000105	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.74e-06	0.000105	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.72e-06	0.000104	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.7e-06	0.000102	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.67e-06	0.0001	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.67e-06	0.0001	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.58e-06	9.51e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.55e-06	9.32e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.55e-06	9.3e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.53e-06	9.22e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.52e-06	9.16e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.45e-06	8.71e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.44e-06	8.66e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.44e-06	8.66e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.43e-06	8.62e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.43e-06	8.62e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.41e-06	8.51e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.4e-06	8.45e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.37e-06	8.26e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.34e-06	8.03e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.33e-06	8.03e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.31e-06	7.88e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.3e-06	7.82e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.28e-06	7.72e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.28e-06	7.69e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.25e-06	7.49e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.23e-06	7.4e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.19e-06	7.18e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.19e-06	7.16e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.18e-06	7.1e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.17e-06	7.04e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.16e-06	6.96e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.12e-06	6.75e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.1e-06	6.63e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	6.61e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.1e-06	6.61e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.09e-06	6.53e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	9.57e-07	5.76e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	9.39e-07	5.65e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	8.99e-07	5.41e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	8.6e-07	5.18e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.3e-07	4.99e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.23e-07	4.95e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.23e-07	4.95e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	7.53e-07	4.53e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.78e-07	2.28e-05	CbGpPWpGaD
